Machine Learning and AI in Cancer Prognosis, Prediction, and Treatment Selection: A Critical Approach
Bo Zhang,Huiping Shi,Hongtao Wang
DOI: https://doi.org/10.2147/JMDH.S410301
2023-06-26
Journal of Multidisciplinary Healthcare
Abstract:Bo Zhang, 1 Huiping Shi, 1 Hongtao Wang 2 1 Jinling Institute of Science and Technology, Nanjing City, Jiangsu Province, People's Republic of China; 2 School of Life Science, Tonghua Normal University, Tonghua City, Jilin Province, People's Republic of China Correspondence: Bo Zhang, Jinling Institute of Science and Technology, No. 99, Hongjing Avenue, Jiangning District, Nanjing City, Jiangsu Province, 211169, People's Republic of China, Email Cancer is a leading cause of morbidity and mortality worldwide. While progress has been made in the diagnosis, prognosis, and treatment of cancer patients, individualized and data-driven care remains a challenge. Artificial intelligence (AI), which is used to predict and automate many cancers, has emerged as a promising option for improving healthcare accuracy and patient outcomes. AI applications in oncology include risk assessment, early diagnosis, patient prognosis estimation, and treatment selection based on deep knowledge. Machine learning (ML), a subset of AI that enables computers to learn from training data, has been highly effective at predicting various types of cancer, including breast, brain, lung, liver, and prostate cancer. In fact, AI and ML have demonstrated greater accuracy in predicting cancer than clinicians. These technologies also have the potential to improve the diagnosis, prognosis, and quality of life of patients with various illnesses, not just cancer. Therefore, it is important to improve current AI and ML technologies and to develop new programs to benefit patients. This article examines the use of AI and ML algorithms in cancer prediction, including their current applications, limitations, and future prospects. Keywords: machine learning, artificial intelligence, treatment selection, cancer diagnosis, cancer-related mortality Cancer is a significant public health issue globally, marked by an elevated incidence and mortality rate. 1 According to the GLOBOCAN 2020 database, approximately 19.3 million new cases and 10 million deaths have been reported annually. 2 Lung cancer remains the most common cause of cancer-related mortality, with expected 1.8 million fatalities, followed by stomach, liver, colorectal, and breast cancer. 2 The prevention and treatment of cancer remain difficult. 3 After heart disease, cancer remains the second leading cause of death in the United States. In 2023, there are projected to be 1.9 million new cancer cases (equivalent to around 5370 cases per day) and 609,820 deaths from cancer (equivalent to around 1670 deaths per day) in the US. The International Agency for Research on Cancer (IARC) has released a poster on known causes and prevention by organ site of human cancer. A description of known causes and prevention by organ site is provided in Figure S1 . The "Global Cancer Observatory" reports indicate that on a global scale, 37 individuals are diagnosed with cancer and over 19 individuals succumb to the disease every minute. Figure 1A shows the number of new cases in 2020 and Figure 1B shows the number of deaths in 2020 due to all cancers. Figure 1 The number of new cancer cases reported in 2020 and the number of deaths caused by these cancers. ( A ). Estimated number of new cases worldwide in 2020 among both sexes. ( B ) Estimated number of deaths worldwide in 2020 among both sexes. Reprinted from World Health Organization. © International Agency for Research on Cancer, 2020. Cancer Today. Available from: https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=cancer&mode_population=continents&population=900&populations=900&key=total&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0 . [Accessed June 20, 2023]. 4 However, the introduction of machine learning and artificial intelligence positively supports cancer prevention and management. 5 Artificial intelligence is commonly defined as a set of computer-coded programs or algorithms that use data analysis and pre-programmed instructions to make predictions and decisions about various aspects of a disease. Machine learning is a specialized field within AI that refers to a group of algorithms designed to automatically learn and improve from experience. In other words, machine learning is an AI subset that focuses on developing algorithms capable of learning from data and refining their performance over time. 6,7 Deep Learning is a subfield of "Machine Learning" that employs neural network-based models to imitate the human brain's capacity to analyze huge amounts of -Abstract Truncated-
health care sciences & services